Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

• Status: Recruiting
• Trial end date: 2022-06-17
• Target enrollment: 0
• Participant gender: All

Summary

This study is a double-blind, parallel-group, randomized study of active drug vs placebo in asthma.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Biohaven Pharmaceuticals, Inc.

Criteria

Inclusion Criteria:

• Subjects with Asthma

Exclusion Criteria:

-